Approval · Notice of Compliance 31686 · 2023
VYVGART: Notice of Compliance 31686
Issued September 19, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31686
- Date
- September 19, 2023
- Company
- Argenx BvZwijnaarde, --, Belgium
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VYVGART | 02541599 | Marketed |
Medicinal ingredients
- EFGARTIGIMOD ALFA 20 MG per ML